Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study

BACKGROUND: Hepatic encephalopathy (HE) is a severe complication in patients with hepatic cirrhosis, which causes numerous hospital admissions and deaths. Antibiotics are the best options in HE treatment, but head-to-head comparisons between these drugs are scarce. Erythromycin combines the antimicr...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeiro, Fernando Gomes, da Silva Yamashiro, Fabio, Américo, Madileine Francely, Corá, Luciana Aparecida, Silva, Giovanni Faria, Miranda, JoséRicardodeArruda, Caramori, Carlos Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551652/
https://www.ncbi.nlm.nih.gov/pubmed/23324408
http://dx.doi.org/10.1186/1471-230X-13-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551652/
https://www.ncbi.nlm.nih.gov/pubmed/23324408
http://dx.doi.org/10.1186/1471-230X-13-13

Ejemplares similares